Overview This page contains the latest trade data of Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts. In 2022, Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts were the world's 1902nd most traded product, with a total trade of $1.38B. Between 2021 and 2022 the exports of Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts grew by 18.3%, from $1.16B to $1.38B. Trade in Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts represent 0.0058% of total world trade.
Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts are a part of Heterocyclic compounds with nitrogen hetero-atom(s) only.
Exports In 2022 the top exporters of Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts were Ireland ($352M), China ($305M), India ($190M), Japan ($82.6M), and Switzerland ($73.1M).
Imports In 2022 the top importers of Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts were United Kingdom ($246M), Japan ($137M), India ($107M), United States ($103M), and Germany ($89.2M).
Ranking Heterocyclic compounds: containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts ranks 219th in the Product Complexity Index (PCI).